Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Chalazion × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 117 Colonic Neoplasms 64 Rectal Neoplasms 58 Breast Neoplasms 53 Stomach Neoplasms 30 Pancreatic Neoplasms 28 Squamous Cell Carcinoma of Head and Neck 22 Neoplasm Metastasis 21 Esophageal Neoplasms 21 Head and Neck Neoplasms 20 Esophageal Squamous Cell Carcinoma 16 Carcinoma, Hepatocellular 14 Adenocarcinoma Of Esophagus 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 11 Nasopharyngeal Carcinoma 11 Neoplasms 10 Adenocarcinoma 6 Keratosis, Actinic 5 Cholangiocarcinoma 5 Anus Neoplasms 5 Urinary Bladder Neoplasms 4 Intestinal Neoplasms 4 Hepatoblastoma 4 Gastrointestinal Neoplasms 4 Digestive System Neoplasms 4 Inflammatory Breast Neoplasms 3 Hypopharyngeal Neoplasms 3 HIV Infections 3 Gastrointestinal Diseases 3 Anal Canal Carcinoma 3

Interventions

Triamcinolone Acetonide 1 Triamcinolone 1 Fluorouracil 1 Curettage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02025023 2020-02-06

CTS

University of Washington

Phase 3 Recruiting

Pain, Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡